• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[特定血清因子在破坏胰岛素与红细胞细胞膜受体结合中的作用]

[The role of specific blood serum factors in disrupting insulin binding to erythrocyte cell membrane receptors].

作者信息

Korpachev V V, Gurina N M, Ivanova Zh V

出版信息

Ukr Biokhim Zh (1978). 1994 Jul-Aug;66(4):65-8.

PMID:7879290
Abstract

The alteration of indices of 125-I insulin binding to receptors in the reactions with human erythrocytes, with their membranes and with solubilized insulin receptors in the presence of type 2 diabetics' blood serum was demonstrated (decrease of the number of insulin binding sites and increase of the dissociation constant). Treatment of patients' erythrocytes with acetate buffer solution (0.1 M, pH 5, 150 mM sodium chloride) restored the level of specific binding of insulin to normal values. It is supposed that in insulin-independent diabetes mellitus patients' serum there are specific blocking factors which interact immediately with insulin receptors thus preventing them from hormone binding or reducing their affinity.

摘要

在2型糖尿病患者血清存在的情况下,证明了125-I胰岛素与人类红细胞、其细胞膜以及可溶性胰岛素受体反应中胰岛素与受体结合指标的改变(胰岛素结合位点数量减少,解离常数增加)。用醋酸盐缓冲溶液(0.1M,pH5,150mM氯化钠)处理患者红细胞可使胰岛素特异性结合水平恢复至正常。推测在非胰岛素依赖型糖尿病患者血清中存在特异性阻断因子,其直接与胰岛素受体相互作用,从而阻止受体与激素结合或降低其亲和力。

相似文献

1
[The role of specific blood serum factors in disrupting insulin binding to erythrocyte cell membrane receptors].[特定血清因子在破坏胰岛素与红细胞细胞膜受体结合中的作用]
Ukr Biokhim Zh (1978). 1994 Jul-Aug;66(4):65-8.
2
[Pyruvate kinase activity as a marker of erythrocyte age increases the reliability of the method of determining insulin binding to membrane receptors].
Vnitr Lek. 1987 Jun;33(6):454-63.
3
Detection of compounds in serum inhibiting insulin binding to erythrocyte receptors.血清中抑制胰岛素与红细胞受体结合的化合物的检测
Endocrinol Exp. 1988 Dec;22(4):203-9.
4
[Correlative study of erythrocyte membrane insulin receptor with blood lipids and albumin in non-obese noninsulin-dependent diabetics (NIDDM) patients before and after exercise].非肥胖型非胰岛素依赖型糖尿病(NIDDM)患者运动前后红细胞膜胰岛素受体与血脂及白蛋白的相关性研究
Zhonghua Yi Xue Za Zhi. 1995 Aug;75(8):486-8, 511-2.
5
Insulin binding on erythrocytes in unsatisfactorily controlled obese diabetics (type 2) and nonobese diabetics (type 1).胰岛素与控制不佳的肥胖糖尿病患者(2型)和非肥胖糖尿病患者(1型)红细胞的结合情况。
Exp Clin Endocrinol. 1985 Aug;86(1):53-60. doi: 10.1055/s-0029-1210472.
6
[Membrane cholesterol and insulin receptor in erythrocytes].[红细胞中的膜胆固醇与胰岛素受体]
Fukuoka Igaku Zasshi. 1991 Nov;82(11):586-602.
7
Erythrocyte insulin receptor characteristics and erythrocyte membrane lipid composition in healthy men.健康男性的红细胞胰岛素受体特征及红细胞膜脂质成分
Physiol Bohemoslov. 1989;38(5):419-25.
8
Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.二甲双胍治疗对正常体重受试者、肥胖非糖尿病受试者、1型和2型糖尿病患者红细胞胰岛素结合的影响。
Diabete Metab. 1986 Aug;12(4):219-24.
9
Characteristics of human erythrocyte insulin binding sites.人类红细胞胰岛素结合位点的特征
Acta Med Okayama. 1981 Apr;35(2):125-35. doi: 10.18926/AMO/31272.
10
Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.
Science. 1979 Jul 13;205(4402):200-2. doi: 10.1126/science.451590.